Physician profile
Brian W Coyle
NPI 1043492028
$2,726.03
in general payments reported to CMS, 2019-2025
20 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $223 · 2021: $313 · 2022: $195 · 2023: $364 · 2024: $500 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,138.73 | 2019-2025 | Ranger, General - Vascular Intervention, Opticross 35 |
| Silk Road Medical, INC. | $575.83 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $208.91 | 2019-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Medtronic, INC. | $160.10 | 2021-2023 | Ellipsys Vascular Access System |
| Philips North America LLC | $106.83 | 2020 | |
| Bolton Medical INC | $105.89 | 2019 | |
| Getinge USA Sales, LLC | $83.21 | 2020 | |
| Smith+Nephew, INC. | $82.91 | 2022-2025 | Renasys Touch, Grafix, Stravix |
| Solventum Corporation | $46.16 | 2024-2025 | Promogran Prisma, Activ.A.C., Prevena |
| Reprise Biomedical, INC. | $27.46 | 2023 | Miro3d |
| Lemaitre Vascular, INC. | $24.82 | 2025 | Xenosure Biologic Patch |
| Janssen Pharmaceuticals, INC | $23.92 | 2021 | |
| Organogenesis INC. | $21.53 | 2023 | Puraply |
| Angiodynamics, INC. | $21.45 | 2020 | |
| Pfizer INC. | $18.46 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $18.40 | 2021 | |
| Cordis US Corp. | $17.55 | 2025 | Mynx Control Venous |
| Abbott Laboratories | $15.97 | 2024 | Jeti Peripheral Catheter |
| E.R. Squibb & Sons, L.L.C. | $14.22 | 2019 | |
| Argon Medical Devices, INC. | $13.68 | 2024 | Clot Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.